• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Infect Dev Ctries . Restraining SARS-CoV-2 in histopathology laboratory amid COVID-19 pandemic

tetano

Editor, Senior Moderator
J Infect Dev Ctries


. 2022 Jan 31;16(1):49-56.
doi: 10.3855/jidc.13894.
Restraining SARS-CoV-2 in histopathology laboratory amid COVID-19 pandemic


Efosa Bolaji Odigie[SUP] 1 [/SUP], Abdulganiy Abu-Ubaid Zakariyya[SUP] 2 [/SUP], Nosa Terry Omorodion[SUP] 2 [/SUP], Blessing Emosho Ogeyehme[SUP] 2 [/SUP], Theophilus Ogie Erameh[SUP] 2 [/SUP], Fatima Bashir Shema[SUP] 3 [/SUP], Dahiru Falalu Ibrahim[SUP] 3 [/SUP], Oladoyin Atanda[SUP] 2 [/SUP], Oyedele Oyewumi Ajayi[SUP] 4 [/SUP], David Temitope Noah[SUP] 3 [/SUP], Abdullahi Alhaji Mairiga[SUP] 5 [/SUP], Abdulaziz Tahir Idris[SUP] 3 [/SUP], Sharafudeen Dahiru Abubakar[SUP] 6 [/SUP], Zakariyya Muhammad Bello[SUP] 6 [/SUP], Halima Saliu Aliu[SUP] 2 [/SUP]



Affiliations

Abstract

Medical laboratory personnel encounter diverse health and workplace-related hazards leading to severe health challenges including the ravaging SARS-CoV-2 infection, which is the causal agent of COVID-19. It was first announced in Wuhan, China in December 2019 but started to spread globally by late January 2020. COVID-19 pandemic and subsequent global spreading poses additional danger to healthcare personnel particularly the laboratorians. Other health practitioners may engage patients by observing social / physical distancing, but how laboratory staff observe or apply same rule to infectious samples remain a notable question. Activities of laboratorians result in repeated exposure at close interactions to patient's samples including SARS-CoV-2 infected specimens, which make them susceptible to COVID-19. Therefore, it is imperative to review mitigating measures in restraining possible exposure and spreading of SARS-CoV-2 in the best interest of laboratory staff and pathologists. It is against this backdrop that this paper intends to update readers on measures to restrain SARS-CoV-2 invasion in histopathology laboratory and deduce precautionary measures for observation by healthcare providers in COVID-19 era. Also discussed, is health hazards associated with histopathology laboratory with the objective of encouraging safety consciousness and safe laboratory practices in the face of COVID-19 pandemic.

Keywords: COVID-19 pandemic; Coronavirus disease 2019; SARS-CoV-2 infection; laboratorians; laboratory disinfection; pathologists.
 
Back
Top Bottom